Literature DB >> 1522489

Concanavalin A microspheres for a self-regulating insulin delivery system.

C M Pai1, Y H Bae, E J Mack, D E Wilson, S W Kim.   

Abstract

A self-regulating insulin delivery system based on the competitive binding of glucose and p-succinylamidophenyl-alpha-D-glycopyranoside-insulin (SAPG-insulin) to crosslinked concanavalin A (Con A) microspheres (MSs) has been investigated. Con A MSs prepared by a water-in-oil emulsion technique demonstrated properties of binding to glucose and SAPG-insulin (binding constants of 1.25 x 10(3) and 1.28 x 10(4) M-1, respectively) that are similar to the literature values of these properties for unmodified Con A. The retained binding capacity (number of binding sites per molecule) of Con A MSs, produced with 20% of the epsilon-amino groups crosslinked, was approximately 28% that of intact Con A. As a new device, Con A MSs loaded with SAPG-insulin was enclosed in a heat-sealed, surface-modified, porous poly(vinylidene difluoride) membrane pouch. This system showed a pulsatile release pattern for insulin with a short lag time in response to glucose challenges of 50-500 mg/dL. The pattern of release of SAPG-insulin from the devices was studied with varying design parameters, such as surface area, membrane pore size, and loading content of SAPG-insulin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1522489     DOI: 10.1002/jps.2600810612

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  Fiber-coupled fluorescence affinity sensor for 3-day in vivo glucose sensing.

Authors:  Ralph Ballerstadt; Colton Evans; Ashok Gowda; Roger McNichols
Journal:  J Diabetes Sci Technol       Date:  2007-05

Review 2.  Responsive polymeric drug delivery systems. Meeting the patient's needs.

Authors:  A D'Emanuele
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

3.  Targeted Mass Spectrometry Approach Enabled Discovery of O-Glycosylated Insulin and Related Signaling Peptides in Mouse and Human Pancreatic Islets.

Authors:  Qing Yu; Alejandra Canales; Matthew S Glover; Rahul Das; Xudong Shi; Yang Liu; Mark P Keller; Alan D Attie; Lingjun Li
Journal:  Anal Chem       Date:  2017-08-07       Impact factor: 6.986

4.  Engineering Synthetically Modified Insulin for Glucose-Responsive Diabetes Therapy.

Authors:  Matthew J Webber; Daniel G Anderson; Robert Langer
Journal:  Expert Rev Endocrinol Metab       Date:  2015-07-18

5.  Preclinical in vivo study of a fluorescence affinity sensor for short-term continuous glucose monitoring in a small and large animal model.

Authors:  Ralph Dutt-Ballerstadt; Colton Evans; Ashok Gowda; Roger McNichols
Journal:  Diabetes Technol Ther       Date:  2008-12       Impact factor: 6.118

Review 6.  Smart approaches to glucose-responsive drug delivery.

Authors:  Matthew J Webber; Daniel G Anderson
Journal:  J Drug Target       Date:  2015       Impact factor: 5.121

7.  Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats.

Authors:  Efstathios Karathanasis; Rohan Bhavane; Ananth V Annapragada
Journal:  Int J Nanomedicine       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.